Pro-2-PAM therapy for central and peripheral cholinesterases
James C Demar1, Edward D Clarkson, Ruthie H Ratcliffe
1Walter Reed Army Institute of Research, Division of Regulated Activities, Department of Regulated Laboratories, Silver Spring, MD 20910-7500, United States.
A new drug, pro-2-PAM, effectively treats organophosphorus (OP) poisoning by crossing the blood-brain barrier to restore central nervous system acetylcholinesterase (AChE) activity and prevent seizures. This novel therapeutic offers a promising solution for OP-induced neurotoxicity.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Organophosphorus (OP) agents are chemical warfare and terrorism threats.
- Current OP exposure therapy uses atropine, pralidoxime chloride (2-PAM), and anticonvulsants.
- Standard oximes like 2-PAM do not cross the blood-brain barrier (BBB), limiting central nervous system (CNS) treatment.
Purpose of the Study:
- To synthesize and evaluate pro-2-PAM, a BBB-permeable 2-PAM derivative.
- To assess pro-2-PAM's efficacy in preventing OP-induced seizures and neurotoxicity in the CNS.
- To compare pro-2-PAM's effectiveness against standard 2-PAM in OP-exposed animals.
Main Methods:
- Synthesis and evaluation of pro-2-PAM, a lipid-permeable 2-PAM derivative.
- Assessment of pro-2-PAM's ability to enter the brain and reactivate CNS acetylcholinesterase (AChE).
- Utilized electroencephalogram (EEG) monitoring, neurohistopathology, cholinesterase activity assays, and survivability studies in guinea pigs exposed to diisopropylfluorophosphate (DFP).
Main Results:
- Pro-2-PAM significantly suppressed and eliminated seizures in DFP-exposed guinea pigs, unlike ineffective 2-PAM.
- Pro-2-PAM treatment resulted in reduced neurological damage and higher CNS AChE activity compared to 2-PAM.
- Both oximes showed similar peripheral nervous system (PNS) AChE activity in blood and diaphragm.
Conclusions:
- Pro-2-PAM successfully crosses the BBB and is metabolized to 2-PAM within the brain.
- Pro-2-PAM effectively prevents OP-induced seizures by restoring CNS AChE activity.
- Pro-2-PAM represents the first non-invasive therapeutic for OP poisoning that targets CNS AChE reactivation.
More Related Videos
06:022-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition
Published on: December 26, 2016
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Cholinesterases: Distribution and Function
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
